Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Total Liabilities (2023 - 2025)

Rallybio's Total Liabilities history spans 3 years, with the latest figure at $4.6 million for Q3 2025.

  • For Q3 2025, Total Liabilities fell 43.5% year-over-year to $4.6 million; the TTM value through Sep 2025 reached $4.6 million, down 43.5%, while the annual FY2024 figure was $6.5 million, 31.6% down from the prior year.
  • Total Liabilities for Q3 2025 was $4.6 million at Rallybio, down from $5.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $9.6 million in Q3 2023 and bottomed at -$89.2 million in Q1 2024.
  • The 3-year median for Total Liabilities is $6.5 million (2024), against an average of -$14.9 million.
  • The largest annual shift saw Total Liabilities tumbled 1352.03% in 2024 before it soared 106.3% in 2025.
  • A 3-year view of Total Liabilities shows it stood at $9.4 million in 2023, then crashed by 31.6% to $6.5 million in 2024, then dropped by 28.31% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Total Liabilities are $4.6 million (Q3 2025), $5.0 million (Q2 2025), and -$54.1 million (Q1 2025).